MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines1

Human blood is a self-regenerating lipid-rich biological fluid that is routinely collected in hospital settings. The inventory of lipid molecules found in blood plasma (plasma lipidome) offers insights into individual metabolism and physiology in health and disease. Disturbances in the plasma lipidome also occur in conditions that are not directly linked to lipid metabolism; therefore, plasma lipidomics based on MS is an emerging tool in an array of clinical diagnostics and disease management. However, challenges exist in the translation of such lipidomic data to clinical applications. These relate to the reproducibility, accuracy, and precision of lipid quantitation, study design, sample handling, and data sharing. This position paper emerged from a workshop that initiated a community-led process to elaborate and define a set of generally accepted guidelines for quantitative MS-based lipidomics of blood plasma or serum, with harmonization of data acquired on different instrumentation platforms across independent laboratories as an ultimate goal. We hope that other fields may benefit from and follow such a precedent.

[1]  Mario Plebani,et al.  Validation model of a laboratory-developed method for the ISO15189 accreditation: The example of salivary cortisol determination. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[2]  Mark Woodward,et al.  Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus , 2016, Circulation.

[3]  Peiyuan Yin,et al.  Serum or plasma, what is the difference? Investigations to facilitate the sample material selection decision making process for metabolomics studies and beyond. , 2018, Analytica chimica acta.

[4]  Xianlin Han,et al.  Selection of internal standards for accurate quantification of complex lipid species in biological extracts by electrospray ionization mass spectrometry-What, how and why? , 2017, Mass spectrometry reviews.

[5]  Erik Peter,et al.  Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. , 2014, Clinical chemistry.

[6]  Yizhao Chen,et al.  An improved reference measurement procedure for triglycerides and total glycerides in human serum by isotope dilution gas chromatography-mass spectrometry. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[7]  M. Kurano,et al.  Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration , 2013, Lipids in Health and Disease.

[8]  P. Meikle,et al.  An Efficient Single Phase Method for the Extraction of Plasma Lipids , 2015, Metabolites.

[9]  Christoph Steinbeck,et al.  MetaboLights—an open-access general-purpose repository for metabolomics studies and associated meta-data , 2012, Nucleic Acids Res..

[10]  Gunnel Tybring,et al.  Metabolomic Quality Assessment of EDTA Plasma and Serum Samples. , 2016, Biopreservation and biobanking.

[11]  E. Dennis,et al.  Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids. , 2015, Biochimica et biophysica acta.

[12]  Zeper Abliz,et al.  Liquid chromatography-tandem mass spectrometry-based plasma metabonomics delineate the effect of metabolites' stability on reliability of potential biomarkers. , 2013, Analytical chemistry.

[13]  Guideline on Bioanalytical Method Validation in Pharmaceutical Development , 2013 .

[14]  Eoin Fahy,et al.  Biomarkers of NAFLD progression: a lipidomics approach to an epidemic1[S] , 2015, Journal of Lipid Research.

[15]  J. Bruce German,et al.  Effects of sample handling and storage on quantitative lipid analysis in human serum , 2009, Metabolomics.

[16]  Changqing Zhang,et al.  Erythrocyte sedimentation rate and fibrinogen concentration of whole blood influences the cellular composition of platelet-rich plasma obtained from centrifugation methods , 2017, Experimental and therapeutic medicine.

[17]  D. Ory,et al.  Development and validation of LC-MS/MS method for determination of very long acyl chain (C22:0 and C24:0) ceramides in human plasma , 2013, Analytical and Bioanalytical Chemistry.

[18]  L. Frøyland,et al.  Effect of storage time, temperature, antioxidant and thawing on fatty acid composition of plasma, serum and red blood cells - A pilot biobank study. , 2017, Clinical biochemistry.

[19]  Edward A Dennis,et al.  Applications of mass spectrometry to lipids and membranes. , 2011, Annual review of biochemistry.

[20]  K. Ikeda,et al.  Comprehensive analyses of oxidized phospholipids using a measured MS/MS spectra library[S] , 2017, Journal of Lipid Research.

[21]  Adam D. Kennedy,et al.  Analytes related to erythrocyte metabolism are reliable biomarkers for preanalytical error due to delayed plasma processing in metabolomics studies. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[22]  David S. Wishart,et al.  HMDB 4.0: the human metabolome database for 2018 , 2017, Nucleic Acids Res..

[23]  David W. Russell,et al.  LMSD: LIPID MAPS structure database , 2006, Nucleic Acids Res..

[24]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[25]  Kai Simons,et al.  How Can Omic Science be Improved? , 2018, Proteomics.

[26]  D. Schwudke,et al.  Shotgun Lipidomics Approach for Clinical Samples. , 2018, Methods in molecular biology.

[27]  Rick Twee-Hee Ong,et al.  Discovering and validating between-subject variations in plasma lipids in healthy subjects , 2016, Scientific Reports.

[28]  V. O’Donnell,et al.  Esterified eicosanoids: generation, characterization and function. , 2012, Biochimica et biophysica acta.

[29]  A. Remaley,et al.  Interferences from blood collection tube components on clinical chemistry assays , 2014, Biochemia medica.

[30]  Yoshiro Saito,et al.  Plasma Lipidomics of Healthy Japanese Adults Reveals Gender- and Age-Related Differences. , 2017, Journal of pharmaceutical sciences.

[31]  D. Giustarini,et al.  Biomarkers of oxidative damage in human disease. , 2006, Clinical chemistry.

[32]  G. FitzGerald,et al.  Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Roger Frost,et al.  International Organization for Standardization (ISO) , 2004 .

[34]  Ian D. Wilson,et al.  Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies , 2018, Metabolomics : Official journal of the Metabolomic Society.

[35]  Florian Kronenberg,et al.  Differences between Human Plasma and Serum Metabolite Profiles , 2011, PloS one.

[36]  Martin Eisenacher,et al.  Proteomics Standards Initiative: Fifteen Years of Progress and Future Work , 2017, Journal of proteome research.

[37]  Catherine A Rimmer,et al.  Development of a Standard Reference Material for metabolomics research. , 2013, Analytical chemistry.

[38]  Ioannis Xenarios,et al.  Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans. , 2017, Cell reports.

[39]  Paulo Pereira,et al.  Part 2-ISO 15189 : 2012 “ Medical laboratories-Requirements for quality and competence ” , 2015 .

[40]  K. Lynch CLSI C62-A: A New Standard for Clinical Mass Spectrometry. , 2016, Clinical chemistry.

[41]  Lennart Martens,et al.  mzML—a Community Standard for Mass Spectrometry Data* , 2010, Molecular & Cellular Proteomics.

[42]  A. Van der Laarse,et al.  Quantifying protein measurands by peptide measurements: where do errors arise? , 2015, Journal of proteome research.

[43]  G. Lippi,et al.  Erythrocyte mechanical fragility is increased in patients with type 2 diabetes. , 2012, European journal of internal medicine.

[44]  L. D. Da Costa,et al.  Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders. , 2013, Blood reviews.

[45]  Matej Oresic,et al.  Data standards can boost metabolomics research, and if there is a will, there is a way , 2015, Metabolomics.

[46]  Rohit Loomba,et al.  Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis1 , 2015, Journal of Lipid Research.

[47]  Kim Ekroos,et al.  Reporting of lipidomics data should be standardized. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[48]  Giuseppe Lippi,et al.  Pre-analytical phase management: a review of the procedures from patient preparation to laboratory analysis , 2017, Scandinavian journal of clinical and laboratory investigation.

[49]  M. Kroll Evaluating interference caused by lipemia. , 2004, Clinical chemistry.

[50]  Juan Antonio Vizcaíno,et al.  Shorthand notation for lipid structures derived from mass spectrometry , 2013, Journal of Lipid Research.

[51]  Rainer Lehmann,et al.  Effects of pre-analytical processes on blood samples used in metabolomics studies , 2015, Analytical and Bioanalytical Chemistry.

[52]  John A. Bowden,et al.  Common cases of improper lipid annotation using high-resolution tandem mass spectrometry data and corresponding limitations in biological interpretation. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[53]  J. Shaw,et al.  Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia[S] , 2015, Journal of Lipid Research.

[54]  H. Bayır,et al.  Characterization of cardiolipins and their oxidation products by LC-MS analysis. , 2014, Chemistry and physics of lipids.

[55]  H. Ikeda,et al.  Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids. , 2007, Analytical biochemistry.

[56]  Lars Löfgren,et al.  The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma[S] , 2012, Journal of Lipid Research.

[57]  Eoin Fahy,et al.  A comprehensive classification system for lipids11 The evaluation of this manuscript was handled by the former Editor-in-Chief Trudy Forte. Published, JLR Papers in Press, February 16, 2005. DOI 10.1194/jlr.E400004-JLR200 , 2005, Journal of Lipid Research.

[58]  Y. Teo,et al.  Lipidomic profiling of plasma in a healthy Singaporean population to identify ethnic specific differences in lipid levels and associations with disease risk factors , 2017 .

[59]  L. Kluijtmans,et al.  Fast and accurate quantitative organic acid analysis with LC-QTOF/MS facilitates screening of patients for inborn errors of metabolism , 2018, Journal of inherited metabolic disease.

[60]  P. Faure,et al.  Simultaneous determination of tryptophan and 8 metabolites in human plasma by liquid chromatography/tandem mass spectrometry. , 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[61]  Edward A Dennis,et al.  The human plasma lipidome. , 2011, The New England journal of medicine.

[62]  A. Bielawska,et al.  Blood sphingolipidomics in healthy humans: impact of sample collection methodology , 2010, Journal of Lipid Research.

[63]  I. Nolte,et al.  Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants , 2017 .

[64]  Christopher P. Thomas,et al.  Quantitative assays for esterified oxylipins generated by immune cells , 2010, Nature Protocols.

[65]  Christer S. Ejsing,et al.  Identification and Annotation of Lipid Species in Metabolomics Studies Need Improvement. , 2015, Clinical chemistry.

[66]  H. Pham,et al.  Time to Face the Fats: What Can Mass Spectrometry Reveal about the Structure of Lipids and Their Interactions with Proteins? , 2012, Journal of The American Society for Mass Spectrometry.

[67]  Lennart Martens,et al.  A Golden Age for Working with Public Proteomics Data , 2017, Trends in biochemical sciences.

[68]  M. A. Surma,et al.  An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids , 2015, European journal of lipid science and technology : EJLST.

[69]  O. Morand,et al.  Plasma Lysosphingomyelin Demonstrates Great Potential as a Diagnostic Biomarker for Niemann-Pick Disease Type C in a Retrospective Study , 2014, PloS one.

[70]  Andreas Zell,et al.  Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. , 2013, Clinical chemistry.

[71]  Oliver Hofmann,et al.  ISA software suite: supporting standards-compliant experimental annotation and enabling curation at the community level , 2010, Bioinform..

[72]  John A. Bowden,et al.  NIST lipidomics workflow questionnaire: an assessment of community-wide methodologies and perspectives , 2018, Metabolomics.

[73]  J. Nofer,et al.  Preanalytical standardization of sphingosine-1-phosphate, sphinganine-1-phosphate and sphingosine analysis in human plasma by liquid chromatography-tandem mass spectrometry. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[74]  Eric Woolf,et al.  Workshop Report: Crystal City V—Quantitative Bioanalytical Method Validation and Implementation: The 2013 Revised FDA Guidance , 2014, The AAPS Journal.

[75]  Matej Oresic,et al.  Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950–Metabolites in Frozen Human Plasma[S] , 2017, Journal of Lipid Research.

[76]  Joshua D. Knowles,et al.  Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry , 2011, Nature Protocols.

[77]  C. Pizarro,et al.  Thawing as a critical pre-analytical step in the lipidomic profiling of plasma samples: New standardized protocol. , 2016, Analytica chimica acta.

[78]  Ruth M. Pfeiffer,et al.  The impact of sample storage time on estimates of association in biomarker discovery studies , 2011, Journal of Clinical Bioinformatics.

[79]  C. Patrono,et al.  Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. , 1982, The Journal of clinical investigation.

[80]  K. Liestøl,et al.  Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality. , 2000, European heart journal.

[81]  M. Hirai,et al.  MassBank: a public repository for sharing mass spectral data for life sciences. , 2010, Journal of mass spectrometry : JMS.

[82]  A. Eschalier,et al.  Fully automated semi-quantitative toxicological screening in three biological matrices using turbulent flow chromatography/high resolution mass spectrometry. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[83]  Lihan Zhou,et al.  Establishing multiple omics baselines for three Southeast Asian populations in the Singapore Integrative Omics Study , 2017, Nature Communications.

[84]  Thomas Hankemeier,et al.  The influence of citrate, EDTA, and heparin anticoagulants to human plasma LC–MS lipidomic profiling , 2012, Metabolomics.

[85]  Poul Thirup,et al.  Haematocrit: within-subject and seasonal variation. , 2003, Sports medicine.

[86]  Stephen E. Stein,et al.  Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resources. , 2013, Analytical chemistry.

[87]  良平 青柳 Comprehensive analyses of oxidized phospholipids using a measured MS/MS spectra library , 2018 .

[88]  Richard D. Beger,et al.  Quality assurance and quality control processes: summary of a metabolomics community questionnaire , 2017, Metabolomics.

[89]  M. Holčapek,et al.  Lipidomic Analysis. , 2018, Analytical chemistry.

[90]  David Moher,et al.  STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies , 2015, BMJ : British Medical Journal.

[91]  M. Mayr,et al.  Lipidomics: Quest for Molecular Lipid Biomarkers in Cardiovascular Disease , 2014, Circulation. Cardiovascular genetics.

[92]  J. Shelhamer,et al.  Dysregulation of lipidomic profile and antiviral immunity in response to hyaluronan in patients with severe asthma. , 2017, The Journal of allergy and clinical immunology.

[93]  T. Grosser,et al.  A broad-spectrum lipidomics screen of antiinflammatory drug combinations in human blood. , 2016, JCI insight.

[94]  Kim Ekroos,et al.  Gender, Contraceptives and Individual Metabolic Predisposition Shape a Healthy Plasma Lipidome , 2016, Scientific Reports.

[95]  Kosuke Saito,et al.  Plasma and Serum Lipidomics of Healthy White Adults Shows Characteristic Profiles by Subjects’ Gender and Age , 2014, PloS one.

[96]  K. Kuulasmaa,et al.  Standardization of total cholesterol measurement in population surveys—pre-analytic sources of variation and their effect on the prevalence of hypercholesterolaemia , 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[97]  E. Dennis,et al.  Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples. , 2014, Journal of chromatography. A.

[98]  Takao Shimizu,et al.  Multiplex quantitative analysis of eicosanoid mediators in human plasma and serum: Possible introduction into clinical testing. , 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[99]  E. C. Chua,et al.  Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humans , 2013, Proceedings of the National Academy of Sciences.

[100]  Gabi Kastenmüller,et al.  Pre-Analytical Sample Quality: Metabolite Ratios as an Intrinsic Marker for Prolonged Room Temperature Exposure of Serum Samples , 2015, PloS one.

[101]  Dana Boyd Barr,et al.  Biological Matrix Effects in Quantitative Tandem Mass Spectrometry-Based Analytical Methods: Advancing Biomonitoring , 2016, Critical reviews in analytical chemistry.

[102]  Bernard Walther,et al.  The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age , 2017, PloS one.

[103]  Pierre Lescuyer,et al.  LacaScore: a novel plasma sample quality control tool based on ascorbic acid and lactic acid levels , 2016, Metabolomics.

[104]  T. Mori,et al.  Minimizing artifactual elevation of lipid peroxidation products (F2-isoprostanes) in plasma during collection and storage. , 2014, Analytical biochemistry.

[105]  Eoin Fahy,et al.  Lipidomics reveals a remarkable diversity of lipids in human plasma1[S] , 2010, Journal of Lipid Research.

[106]  M. Orešič,et al.  Lipidomics in biomedical research-practical considerations. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[107]  Kim Ekroos,et al.  High throughput quantitative molecular lipidomics. , 2011, Biochimica et biophysica acta.

[108]  Kim Ekroos,et al.  Long-term performance and stability of molecular shotgun lipidomic analysis of human plasma samples. , 2013, Analytical chemistry.

[109]  Simone Wahl,et al.  Long-Term Stability of Human Plasma Metabolites during Storage at -80 °C. , 2018, Journal of proteome research.

[110]  Gerd Schmitz,et al.  High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). , 2006, Biochimica et biophysica acta.

[111]  Xianlin Han,et al.  Novel advances in shotgun lipidomics for biology and medicine. , 2016, Progress in lipid research.

[112]  G B Boylan,et al.  The effect of haemolysis on the metabolomic profile of umbilical cord blood. , 2015, Clinical biochemistry.

[113]  Stefan R Bornstein,et al.  A novel informatics concept for high-throughput shotgun lipidomics based on the molecular fragmentation query language , 2011, Genome Biology.

[114]  J. Stephens,et al.  Variation in thromboxane B2 concentrations in serum and plasma in patients taking regular aspirin before and after clopidogrel therapy , 2015, Platelets.

[115]  Christos T. Nakas,et al.  Does centrifugation matter? Centrifugal force and spinning time alter the plasma metabolome , 2016, Metabolomics.

[116]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[117]  Xianlin Han,et al.  Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences. , 2016, Trends in biochemical sciences.

[118]  Michael Schroeder,et al.  LipidXplorer: A Software for Consensual Cross-Platform Lipidomics , 2012, PloS one.

[119]  C. Serhan,et al.  Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. , 2014, American journal of physiology. Cell physiology.

[120]  Jim Vaught,et al.  Preanalytical variables affecting the integrity of human biospecimens in biobanking. , 2015, Clinical chemistry.

[121]  Lennart Martens,et al.  The minimum information about a proteomics experiment (MIAPE) , 2007, Nature Biotechnology.

[122]  B. Dahlbäck,et al.  Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation , 2015, Analytical and Bioanalytical Chemistry.

[123]  J. Shaw,et al.  Plasma lipid profiling in a large population-based cohort[S] , 2013, Journal of Lipid Research.

[124]  S. Dahlén,et al.  Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD , 2016, European Respiratory Journal.

[125]  T. Ebbels,et al.  Optimizing the use of quality control samples for signal drift correction in large-scale urine metabolic profiling studies. , 2012, Analytical chemistry.

[126]  Cynna Selvy,et al.  Clinical Laboratory Improvement Amendments (CLIA) , 2015 .

[127]  R. Laaksonen,et al.  Development and validation of a high-throughput LC–MS/MS assay for routine measurement of molecular ceramides , 2016, Analytical and Bioanalytical Chemistry.

[128]  S. Watson,et al.  Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets. , 2014, Circulation research.

[129]  Maimuna Mendy,et al.  Quality Control of Serum and Plasma by Quantification of (4E,14Z)-Sphingadienine-C18-1-Phosphate Uncovers Common Preanalytical Errors During Handling of Whole Blood. , 2018, Clinical chemistry.

[130]  Nora Nikolac,et al.  Lipemia: causes, interference mechanisms, detection and management , 2014, Biochemia medica.

[131]  G. Koski,et al.  Heparin-enhanced plasma phospholipase A2 activity and prostacyclin synthesis in patients undergoing cardiac surgery. , 1995, The Journal of clinical investigation.

[132]  C. Nielsen,et al.  The effect of centrifugation speed and time on pre-analytical platelet activation , 2016, Clinical chemistry and laboratory medicine.

[133]  Matej Oresic,et al.  COordination of Standards in MetabOlomicS (COSMOS): facilitating integrated metabolomics data access , 2015, Metabolomics.

[134]  U. Ceglarek,et al.  Preanalytical Investigation of Polyunsaturated Fatty Acids and Eicosanoids in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry. , 2016, Biopreservation and biobanking.

[135]  M. Mayr,et al.  Potential and Caveats of Lipidomics for Cardiovascular Disease , 2016, Circulation.